Drug Development Drug Trials Pharmacokinetics Regulations 
Drug Target Review
OCTOBER 3, 2024
Aside from the advent of complex antibody-based drugs, the industry is facing some additional changes which are shaping drug development. 3 This change signals a major shift away from animal use in drug safety regulation and encourages the use of alternative methods like organ-on-chip or other animal-free technologies.
Drug Target Review
SEPTEMBER 19, 2023
This major shift to the orthodox tradition of using animal experiments in drug testing dates back the Aristotle’s time and cemented 80 years ago with initial federal mandate of drug safety regulation of 1938.
Alta Sciences
JULY 31, 2024
Food and Drug Administration (FDA) published a draft guidance to ensure greater diversity in clinical trials, which is expected to become a final guidance by June 2025. Why Diversity in Clinical Trials Matters A wide variety of factors, from age or biological sex to environmental conditions and lifestyle choices (e.g.,
Expert insights. Personalized for you.
52 
Let's personalize your content